PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 259.50
Bid: 259.50
Ask: 260.50
Change: -1.00 (-0.38%)
Spread: 1.00 (0.385%)
Open: 257.00
High: 260.50
Low: 256.50
Prev. Close: 260.50
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio management: Spire Tunbridge Wells

3 Apr 2024 07:00

RNS Number : 0558J
Spire Healthcare Group PLC
03 April 2024
 

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Portfolio management: Spire Tunbridge Wells Hospital

 

3 April 2024

 

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, announces the sale of one of its leasehold hospitals, Spire Tunbridge Wells, to the Maidstone and Tunbridge Wells NHS Trust ('the Trust'), a major acute hospital trust in the south-east of England. The transaction includes the sale of the business and assets of Spire Tunbridge Wells. The consideration was £9.975m. The sale was completed on 31 March 2024.

 

Spire Healthcare remains committed to growth and takes a consistent and proactive approach to portfolio management. Following the transaction, the Group operates 38 hospitals (19 freehold and 19 leasehold properties). This transaction reflects Spire Healthcare's continued focus on disciplined capital allocation and meeting its stated ROCE targets.

 

Following completion of the transaction for a period expected to be around six months, Spire Healthcare will manage the hospital operations on behalf of the Trust continuing to provide treatment to both private and NHS patients.

 

Spire Tunbridge Wells is rated Good by the CQC, comprising 28 beds, 10 consulting rooms, 2 operating theatres and an endoscopy suite. Approximately 130 consultants operate from the hospital. For the year ended 31 December 2023, the hospital generated revenue of £12.7m and EBITDA of £1.1m. Leasehold rent incurred during the period was £0.4m and net cash generation (excluding working capital movements) was £0.7m. Capital expenditure during the year was £0.4m.

 

- Ends -

 

For further information please contact:

 

Spire Healthcare

Angus Prentice - Director of Investor Relations

 

+44 (0)7974 982 512

 

Instinctif Partners

Damian Reece

Guy Scarborough

 

+44 (0)7931 598 593

+44 (0)7917 178 920

 

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

 

About Spire Healthcare

 

Spire Healthcare is a leading independent healthcare group in the United Kingdom, with 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over one million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services.

 

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good,' 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSSMFAEELSESL
Date   Source Headline
19th Dec 20227:00 amRNSAcquisition of The Doctors Clinic Group Limited
1st Dec 202210:02 amRNSTotal Voting Rights
1st Nov 20221:24 pmRNSTotal Voting Rights
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company
15th Aug 20227:00 amRNSNotice of Interim Results
4th Aug 20222:11 pmRNSHolding(s) in Company
1st Aug 20222:43 pmRNSTotal Voting Rights
19th Jul 20229:07 amRNSBlock listing Interim Review
14th Jul 20223:48 pmRNSHolding(s) in Company
13th Jul 20224:43 pmRNSHolding(s) in Company
6th Jul 20224:00 pmRNSDirector/PDMR Shareholding
1st Jul 202210:28 amRNSTotal Voting Rights
29th Jun 20223:56 pmRNSHolding(s) in Company
29th Jun 20227:00 amRNSCapital Markets Event and new agreement with BUPA
1st Jun 20227:54 amRNSTotal Voting Rights
19th May 20227:44 amRNSHolding(s) in Company
18th May 20223:15 pmRNSHolding(s) in Company
13th May 202210:43 amRNSDirector/PDMR Shareholding
11th May 20224:25 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
6th May 20227:00 amRNSNotice of Capital Markets Day
3rd May 20228:46 amRNSTotal Voting Rights
27th Apr 20223:49 pmRNSDirector/PDMR Shareholding
6th Apr 20229:55 amRNSDirector/PDMR Shareholding
1st Apr 20224:40 pmRNS2021 Annual Report and 2022 Notice of AGM
1st Apr 202212:32 pmRNSHolding(s) in Company
1st Apr 202211:10 amRNSTotal Voting Rights
25th Mar 20222:51 pmRNSBlock listing application
24th Mar 20225:16 pmRNSHolding(s) in Company
16th Mar 20228:07 amRNSDirector/PDMR Shareholding
9th Mar 20227:43 amRNSHolding(s) in Company
4th Mar 20226:12 pmRNSHolding(s) in Company
4th Mar 20223:14 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20227:23 amRNSTotal Voting Rights
25th Feb 202212:21 pmRNSHolding(s) in Company
25th Feb 20227:00 amRNSRe-financing of funding facilities
22nd Feb 20223:26 pmRNSHolding(s) in Company
22nd Feb 20221:38 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSManagement update
8th Feb 20227:00 amRNSNotice of Preliminary Results
1st Feb 20229:29 amRNSTotal Voting Rights
27th Jan 20222:57 pmRNSTotal Voting Rights
18th Jan 20227:00 amRNSUpdate on shareholder views
13th Jan 20224:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.